Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

»çÀ̹ö³ªÀÌÇÁÀÇ Ç°Áú°ü¸® ÀýÂ÷¼­ °³¹ß The Development of Quality Assurance Program for CyberKnife

´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö 2006³â 24±Ç 3È£ p.185 ~ 191
ÀåÁö¼±, À̵¿ÇÑ, ½Åµ¿¿À, ±è¹®Âù, À±¼¼Ã¶, ÃÖÀϺÀ, ±è¹Ì¼÷, ·ù¼º·Ä, ±Ç¼öÀÏ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀåÁö¼± ( Jang Ji-Sun ) 
°­³²¼º¸ðº´¿ø »çÀ̹ö³ªÀÌÇÁ¼¾ÅÍ

À̵¿ÇÑ ( Lee Dong-Han ) 
¿øÀÚ·ÂÀÇÇпø »çÀ̹ö³ªÀÌÇÁ¼¾ÅÍ
½Åµ¿¿À ( Shin Dong-Oh ) 
°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ¹æ»ç¼±Á¾¾ç°úÇб³½Ç
±è¹®Âù ( Kim Moon-Chan ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ¿Ü°úÇб³½Ç
À±¼¼Ã¶ ( Yoon Sei-Chul ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¹æ»ç¼±Á¾¾çÇб³½Ç
ÃÖÀϺÀ ( Choi Ihl-Bohng ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¹æ»ç¼±Á¾¾çÇб³½Ç
±è¹Ì¼÷ ( Kim Mi-Sook ) 
¿øÀÚ·ÂÀÇÇпø ¹æ»ç¼±Á¾¾çÇаú
·ù¼º·Ä ( Yoo Seong-Yul ) 
¿øÀÚ·ÂÀÇÇпø ¹æ»ç¼±Á¾¾çÇаú
±Ç¼öÀÏ ( Gwon Soo-Il ) 
°æ±â´ëÇб³ ÀÇÇй°¸®Çаú

Abstract

¸ñ Àû: ±¹³» ½ÇÁ¤¿¡ ÀûÇÕÇÑ »çÀ̹ö³ªÀÌÇÁÀÇ Ç¥ÁØÈ­µÈ Ç°Áú°ü¸® ÀýÂ÷¼­°¡ ¾ø¾î À̸¦ °³¹ßÇÏ°í À¯¿ë¼ºÀ» Æò°¡ÇÏ°íÀÚ ÇÑ´Ù.

´ë»ó ¹× ¹æ¹ý: »çÀ̹ö³ªÀÌÇÁÀÇ ±¸Á¶Àû Ư¼º°ú Ä¡·á ¹æ¹ý µîÀ» °í·ÁÇÏ¿© Ç°Áú°ü¸® °Ë»çÇ׸ñÀ» ¼³Á¤ÇÑ ÈÄ, ÀûÇÕÇÑ ½ÃÇà ½Ã±â¿¡ ¸ÂÃß¾î ÁÖ±âÀû ºÐ·ù¸¦ ÇÏ¿´´Ù. ±×¸®°í ¼³Á¤µÈ Ç׸ñµéÀº °¢°¢ÀÇ Ç°Áú°ü¸® ¸ñÀû¿¡ µû¶ó ÀϹÝÀûÀÎ Ç°Áú°ü¸®(basic QC), Ä¡·áÁ¤È®µµ Ç°Áú°ü¸®(delivery specific QC), ȯÀÚ ¸ÂÃãÇü Ç°Áú°ü¸®(patient specific QC) µî 3°³ÀÇ ºÐ¾ß·Î ±¸ºÐÇÏ¿´´Ù. ±¹³»ÀÇ µÎ °³ ±â°üÀ» ´ë»óÀ¸·Î °³¹ßµÈ Ç°Áú°ü¸® ÀýÂ÷¼­ÀÇ °¢ Ç׸ñÀ» ºñ±³ÇÏ¿© Çã¿ë¿ÀÂ÷¸¦ ºÐ¼®ÇÏ¿´´Ù. ¼³Á¤µÈ Ç׸ñ¿¡ ´ëÇÑ Çã¿ë ¿ÀÂ÷´Â Á¦Àۻ翡¼­ Á¦°øµÈ Ç°Áú°ü¸® ÀÚ·á¿Í ÇöÀç ±¹³»¿¡ ¼³Ä¡µÇ¾î ÀÖ´Â µÎ °³ ±â°üÀÇ ÃÖ±Ù 3³â°£ÀÇ Ç°Áú°ü¸® ¼öÇà µ¥ÀÌÅÍ µîÀ» ±Ù°ÅÇÏ¿´À¸¸ç, °¢ Ç׸ñ¿¡ ´ëÇÑ ÃøÁ¤ °á°ú¸¦ Åä´ë·Î Ç°Áú°ü¸® ½ÇŸ¦ ºÐ¼®ÇÏ°í °³¹ßµÈ Ç°Áú°ü¸® ÀýÂ÷¼­ÀÇ Å¸´ç¼ºÀ» °ËÁõÇÏ¿´´Ù.

°á °ú: °³¹ßµÈ »çÀ̹ö³ªÀÌÇÁ Ç°Áú°ü¸® ÀýÂ÷¼­ÀÇ Ç׸ñ¿¡ ´ëÇÏ¿© µÎ °³ ±â°üÀ» ´ë»óÀ¸·Î Á¤È®¼ºÀ» »óÈ£ ºñ±³ ºÐ¼®ÇÏ¿´´Ù. ¸ðµç ÃøÁ¤ °á°ú´Â »çÀ̹ö³ªÀÌÇÁÀÇ Ç°Áú°ü¸® ÀýÂ÷¼­¿¡¼­ Á¦½ÃÇÑ Çã¿ë¿ÀÂ÷ ¹üÀ§ ³»¿¡¼­ ÀÏÄ¡ÇÏ°í ÀÖÀ½À» È®ÀÎÇÏ¿´´Ù.

°á ·Ð: º» ¿¬±¸¿¡¼­ °³¹ßµÈ Ç°Áú°ü¸® ÀýÂ÷¼­¸¦ ÅëÇØ »çÀ̹ö³ªÀÌÇÁ¿¡ ´ëÇÑ ¼º´ÉÆò°¡ ±âÁØÀ» È®¸³ÇÒ ¼ö ÀÖÀ¸¸ç, ¿µ»óÀ¯µµ Á¤À§¹æ»ç¼±Ä¡·á¿¡ ´ëÇÑ Á¤È®¼º ¹× ¾ÈÀü¼ºÀ» È®º¸ÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î »ý°¢µÈ´Ù.

Purpose: Standardization quality assurance (QA) program of CyberKnife for suitable circumstances in Korea has not been established. In this research, we investigated the development of QA program for CyberKnife and evaluation of the feasibility under applications.

Materials and Methods: Considering the feature of constitution for systems and the therapeutic methodology of CyberKnife, the list of quality control (QC) was established and divided dependent on the each period of operations. And then all these developed QC lists were categorized into three groups such as basic QC, delivery specific QC, and patient specific QC based on the each purpose of QA. In order to verify the validity of the established QA program, this QC lists was applied to two CyberKnife centers. The acceptable tolerance was based on the undertaking inspection list from the CyberKnife manufacturer and the QC results during last three years of two CyberKnife centers in Korea. The acquired measurement results were evaluated for the analysis of the current QA status and the verification of the propriety for the developed QA program.

Results: The current QA status of two CyberKnife centers was evaluated from the accuracy of all measurements in relation with application of the established QA program. Each measurement result was verified having a good agreement within the acceptable tolerance limit of the developed QA program.

Conclusion: It is considered that the developed QA program in this research could be established the standardization of QC methods for CyberKnife and confirmed the accuracy and stability for the image-guided stereotactic radiotherapy.

Å°¿öµå

»çÀ̹ö³ªÀÌÇÁ;Á¤À§¹æ»ç¼±Ä¡·á;Ç°Áú°ü¸® ÀýÂ÷¼­
CyberKnife;Stereotactic radiotherapy;Quality assurance program

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS